Simvastatin abates development of renal fibrosis in experimental renovascular disease

被引:63
作者
Chade, Alejandro R. [1 ]
Zhu, Xiang Yang [1 ]
Grande, Joseph P. [2 ]
Krier, James D. [1 ]
Lerman, Amir
Lerman, Lilach O. [1 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Lab Med & Pathol, Rochester, MN 55905 USA
关键词
atherosclerosis; epithelial-to-mesenchymal transition; kidney; remodeling; simvastatin;
D O I
10.1097/HJH.0b013e328302833a
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and objectives Epithelial-to-mesenchymal transition contributes to renal fibrogenesis, which is regulated by profibrogenic and antifibrogenic mediators. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors can prevent epithelial-to-mesenchymal transition in some models. Therefore, we tested the hypothesis that epithelial-to-mesenchymal transition participates in renal injury in porcine atherosclerotic renovascular disease and can be attenuated by simvastatin. Methods Renal hemodynamics, function, and endothelial function were quantified in vivo in pigs after 12 weeks of combined hypercholesterolemia + renal artery stenosis without (n = 8) or with oral simvastatin supplementation (1.2 mg/kg, n = 6), and in controls (n = 8). Ex-vivo studies assessed renal immunoreactivity to fibrogenic factors and renal histology. Results Blood pressure, cholesterol levels, and basal renal function were similar in treated and untreated pigs with hypercholesterolemia + renal artery stenosis. Hypercholesterolemia + renal artery stenosis significantly upregulated renal transforming growth factor-beta signaling and elicited epithelial-to-mesenchymal transition, accompanied by glomerulosclerosis and renal fibrosis. Simvastatin did not affect smad 2/3 expression but upregulated expression of hepatocyte growth factor, bone morphogenetic factor-7, and smad 7 and prevented most of these renal structural and functional alterations. Furthermore, simvastatin improved renal blood flow response to endothelium-dependent challenge (+111.3 +/- 35.5 vs. -30.4 +/- 18.7 ml/min in untreated pigs, P<0.05). Conclusion Simvastatin upregulates inhibitors of transforming growth factor-beta signaling, attenuates epithelial-to-mesenchymal transition, and decreases renal fibrosis in hypercholesterolemia + renal artery stenosis. These lipid-lowering-independent effects result in improvement of renal function, suggesting clinically valuable potential for statins in preserving the stenotic kidney and limiting deterioration of renal function in atherosclerotic renovascular disease.
引用
收藏
页码:1651 / 1660
页数:10
相关论文
共 58 条
[21]   Renovascular hypertension and ischemic nephropathy [J].
Garovic, VD ;
Textor, SC .
CIRCULATION, 2005, 112 (09) :1362-1374
[22]   Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: Targeting the inflamed vascular endothelium [J].
Gong, Rujun ;
Rifai, Abdalla ;
Dworkin, Lance D. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2464-2473
[23]   TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells [J].
Gore-Hyer, E ;
Shegogue, D ;
Markiewicz, M ;
Lo, SL ;
Hazen-Martin, D ;
Greene, EL ;
Grotendorst, G ;
Trojanowska, M .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (04) :F707-F716
[24]   Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine [J].
HaslerRapacz, J ;
Kempen, HJ ;
Princen, HMG ;
Kudchodkar, BJ ;
Lacko, A ;
Rapacz, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :137-143
[25]   Risk factors for early epithelial to mesenchymal transition in renal grafts [J].
Hertig, A. ;
Verine, J. ;
Mougenot, B. ;
Jouanneau, C. ;
Ouali, N. ;
Sebe, P. ;
Glotz, D. ;
Ancel, P. -Y. ;
Rondeau, E. ;
Xu-Dubois, Y. -C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :2937-2946
[26]   Simastatin and L-arginine preserve renal function after ischemia/reperfusion injury [J].
Inman, SR ;
Davis, NA ;
Mazzone, ME ;
Olson, KM ;
Lukaszek, VA ;
Yoder, KN .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (01) :13-17
[27]   Contractile properties of afferent and efferent arterioles [J].
Ito, S ;
Abe, K .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (07) :532-535
[28]  
Järvisalo MJ, 2006, CURR OPIN CLIN NUTR, V9, P547
[29]   Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function [J].
Krier, JD ;
Ritman, EL ;
Bajzer, Z ;
Romero, JC ;
Lerman, A ;
Lerman, LO .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (04) :F630-F638
[30]   Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells [J].
Lan, HY .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (01) :25-29